Sickle cell disease (SCD) is a devastating hemolytic disease characterized by recurring episodes of painful vaso-occlusion, leading to ischemia-reperfusion injury and organ damage. Despite significant advances in the knowledge of sickle hemoglobin and red blood cells, we still lack a clear understanding of the pathophysiology and treatment of vaso-occlusion. It is now understood that oxidative stress is a trigger for vascular inflammation which promotes vaso-occlusion. Recently the critical roles of endothelial cell activation and inflammation in vaso-occlusion have been recognized, in part due to the development of transgenic murine models of SCD. However, a critical gap exists in explaining how does the sickle patient defend or adapt to excessive hemolysis with the release of hemoglobin/heme/iron into the vasculature and the exuberant production of reactive oxygen species. To remove this heme burden and lessen the oxidative stress, the vasculature increases the expression of heme oxygenase-1 (HO-1). HO-1 is a highly adaptable anti-inflammatory defense against excessive heme burdens. We hypothesize that HO-1, an adaptive, anti- inflammatory gene, plays a critical role in the inhibition and resolution of vaso-occlusion in SCD.
In Specific Aim 1, we will test whether HO-1 and its downstream products, including carbon monoxide, biliverdin/bilirubin and ferritin, manipulated pharmacologically or with gene therapy, will prevent hypoxia/reoxygenation-induced stasis, ameliorate organ pathology and prolong life span in transgenic sickle mice.
In Specific Aim 2, we will identify the mechanisms whereby HO-1 modulates SCD in SCD by examining the effects of HO-1 and its products on oxidative stress, NF-kB activation and endothelial cell adhesion molecule expression. We will demonstrate that adaptative increases in HO-1 activity in SCD are inadequate to handle the excessive heme burden. We expect that further upregulation of HO-1 activity and/or its downstream products will be important strategies to develop innovative new therapies to prevent and treat vaso-occlusion in SCD. This research on inflammation using mouse models of sickle cell anemia wilt identify new targets for drug therapies to alleviate the complications of SCD. These new treatments should decrease sickle crises, prevent organ damage, improve quality and length of lives of sickle cell anemia patients. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL067367-05A2
Application #
7098220
Study Section
Erythrocyte and Leukocyte Biology Study Section (ELB)
Program Officer
Evans, Gregory
Project Start
2001-04-01
Project End
2007-08-31
Budget Start
2006-09-27
Budget End
2007-07-31
Support Year
5
Fiscal Year
2006
Total Cost
$373,750
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Vercellotti, Gregory M; Moldow, Charles F; Jacob, Harry S (2012) Complement, oxidants, and endothelial injury: how a bedside observation opened a door to vascular biology. J Clin Invest 122:3044-5
Beckman, Joan D; Chen, Chunseng; Nguyen, Julia et al. (2011) Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J Biol Chem 286:3194-202
Belcher, John D; Beckman, Joan D; Balla, Gyorgy et al. (2010) Heme degradation and vascular injury. Antioxid Redox Signal 12:233-48
Belcher, John D; Vineyard, Julie V; Bruzzone, Carol M et al. (2010) Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease. J Mol Med (Berl) 88:665-75
Nagy, Emoke; Eaton, John W; Jeney, Viktória et al. (2010) Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol 30:1347-53
Beckman, Joan D; Belcher, John D; Vineyard, Julie V et al. (2009) Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am J Physiol Heart Circ Physiol 297:H1243-53
Jeney, Viktória; Komódi, Edina; Nagy, Emõke et al. (2009) Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S). Free Radic Biol Med 46:616-23
Bruzzone, Carol M; Belcher, John D; Schuld, Nathan J et al. (2008) Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy. Transl Res 152:290-7
Belcher, John D; Mahaseth, Hemachandra; Welch, Thomas E et al. (2006) Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116:808-16
Belcher, John D; Mahaseth, Hemchandra; Welch, Thomas E et al. (2005) Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 288:H2715-25

Showing the most recent 10 out of 12 publications